Aplysia acetylcholine receptors: blockade by and binding of alpha-bungarotoxin.
D000109:Acetylcholine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001667:Binding, Competitive; D002038:Bungarotoxins / Q000494:pharmacology*; D003650:Decamethonium Compounds / Q000494:pharmacology; D004246:Dimethylphenylpiperazinium Iodide / Q000494:pharmacology; D004336:Drug Antagonism; D004594:Electrophysiology; D005703:Gallamine Triethiodide / Q000494:pharmacology; D005730:Ganglionic Blockers; D006584:Hexamethonium Compounds / Q000494:pharmacology; D007457:Iodine Radioisotopes; D007700:Kinetics; D008688:Methacholine Compounds / Q000494:pharmacology; D008974:Mollusca / Q000187:drug effects*; D009388:Neostigmine / Q000494:pharmacology; D009474:Neurons / Q000187:drug effects; D010042:Ouabain / Q000494:pharmacology; D010830:Physostigmine / Q000494:pharmacology; D011950:Receptors, Cholinergic / Q000187:drug effects*; D014403:Tubocurarine / Q000494:pharmacology
D002038:Bungarotoxins; D003650:Decamethonium Compounds; D005730:Ganglionic Blockers; D006584:Hexamethonium Compounds; D007457:Iodine Radioisotopes; D008688:Methacholine Compounds; D011950:Receptors, Cholinergic; D009388:Neostigmine; D004246:Dimethylphenylpiperazinium Iodide; D010042:Ouabain; D001285:Atropine; D010830:Physostigmine; D000109:Acetylcholine; D005703:Gallamine Triethiodide; D014403:Tubocurarine